Our meta-analysis summarized for the first time all the available data on the association between TNF-α-238G/A polymorphism and prostate cancer risk, including a total of five studies, involving 1,967 prostate cancer cases and 2,004 controls. Here, TNF is linked to prostate carcinoma.